DT

Diabetes Technology & Therapeutics

This peer-reviewed journal provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.

Looking to publish in Diabetes Technology & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Endocrinology & Metabolism
Impact Factor 6.3
Quartile Q1
Open Access Type Hybrid
ISSN 1520-9156
eISSN 1557-8593
Invitation Only No
Cost Range Subscription journal with mandatory page charges of $90/page upon acceptance; optional open access publishing is available via Sage Choice for a fee.

Submission Instructions

Diabetes Technology & Therapeutics accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover letter is required only if third-party writing or editing assistance was used or if the submission was made by someone not listed as an author. Cover letter must disclose any third-party writing or editing assistance and state if the submission was made on behalf of the authors by someone not listed as an author.
Abstract Structured abstract is required. Abstract must not exceed 300 words. Abstract must be structured.
Manuscript Manuscript must not exceed 5,000 words, excluding the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, and references. Manuscript must include clearly defined sections with clear heading levels, with the abstract placed between the title and the main body. Manuscript must include at least 4 keywords, an Author Contributions section after the Acknowledgements, a 'Statements and Declarations' section at the end of the article, and a graphical abstract image including the title, brief methods, results, conclusions, and a creator credit line.
References References must use Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, with identical spelling and year in corresponding citations.
Figures & Tables A maximum of 8 tables and/or figures is allowed. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Review Articles

Cover Letter A cover letter is required if third-party writing or editing assistance was used or if the submission was made on behalf of the authors by a non-author. The cover letter must disclose any third-party writing or editing assistance and whether the submission was made on behalf of the authors by someone who is not an author.
Abstract Review Articles must include an abstract. The abstract must be unstructured and no more than 300 words. The abstract must be unstructured.
Manuscript The manuscript must not exceed 6,000 words. The manuscript must include clearly defined sections with clear heading levels. The manuscript must include at least 4 keywords after the abstract, an Author Contributions section, a 'Statements and Declarations' section, and a graphical abstract image including the title, brief methods, results, conclusions, and a creator credit line.
References References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, with identical spelling and year in both places.
Figures & Tables Review Articles may include a maximum of eight tables and/or figures. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Brief Reports

Cover Letter A cover letter is required if writing or editing assistance from a third party was used or if submission was made on behalf of the authors by someone not listed as an author. The cover letter must disclose any third-party writing or editing assistance and state if the submission was made on behalf of the authors by a non-author.
Abstract Brief Reports must include an abstract. The abstract must be unstructured and no more than 150 words. The abstract must be unstructured.
Manuscript The manuscript must not exceed 2,000 words, excluding the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, and references. The manuscript must place the abstract between the title and the main body and include Acknowledgements, Author Contributions, and a final section headed 'Statements and Declarations'. The manuscript must include at least 4 keywords after the abstract and a graphical abstract image containing the title, brief methods, results, conclusions, and a creator credit line.
References References must follow Sage Vancouver style. Every in-text citation must have a matching reference list entry and vice versa, with identical spelling and year in corresponding citations.
Figures & Tables Brief Reports may include a maximum of one figure and one table. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract must be included. The abstract may be structured or unstructured according to the format required for the article type.
Manuscript Letters To The Editor must not exceed 500 words. Sections must be clearly defined with clear heading levels. At least 4 keywords must follow the abstract, and the manuscript must include an Author Contributions section and a 'Statements and Declarations' section after the Acknowledgements section if applicable.
References Letters To The Editor must not exceed five references. References and citations must use Sage Vancouver style. Reference citations must be identical in style to those of full original articles, and every in-text citation must have a corresponding reference list entry and vice versa.
Figures & Tables Letters To The Editor may include one figure or one table.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Observational Letter

Cover Letter Any writing or editing assistance from a third party and any submission made by a non-author on behalf of the authors must be disclosed in the covering letter.
Abstract An abstract must be included. The abstract may be structured or unstructured according to the article type format.
Manuscript The manuscript must not exceed 750 words, excluding the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, and references. Heading levels must be clear and sections clearly defined, with an Author Contributions section after the Acknowledgements and a final section headed 'Statements and Declarations.' At least 4 keywords must appear after the abstract, and the manuscript must include Author Contributions and a 'Statements and Declarations' section even when entries are marked 'Not applicable.'
References The article must not exceed five references. References must use Sage Vancouver style. Reference citations must follow the same style as full original articles, and every in-text citation must correspond exactly to a reference list entry and vice versa.
Figures & Tables The article may include one figure or one table. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Recent Publications

Real-World Data from U.S. Commercial Users of the 365-Day Implantable Eversense Continuous Glucose Monitoring System, Including with the Twiist Automated Insulin Delivery System Integration

Francine Kaufman, Ishaan Jain, Shaoling Han, Colleen Mdingi

10.1177/15209156261486125
View Publication

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review

Konstantinos Kitsios, Christina-Maria Trakatelli

10.1177/15209156261486127
View Publication

Optimizing Continuous Glucose Monitoring for Older Adults with Diabetes: From Clinical Evidence to a Practical Implementation Pathway

Tong Yang, Jinghao Cai, Jiaying Ni, Jingyi Lu, Jian Zhou

10.1177/15209156261485635
View Publication

Real-Time Continuous Glucose Monitoring Improves Glycemic Control in the Early Postoperative Period Following Liver Transplantation: A Randomized Controlled Trial

Marek Protus, Barbora Voglova Hagerf, Antonin Jabor, Janka Franekova, Lenka Nemetova, Eva Uchytilova, Veronika Indrova, Jana Beckova, Alexander Macek, Martina Doleckova, Milos Mraz, Martin Haluzik, Peter Girman, Martina Viravova, Jan Benes, David C. Klonoff, Eva Kieslichova

10.1177/15209156261480872
View Publication

Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care

Ana Piñar-Gutiérrez, José María Madruga-Rubio, Noelia Gros-Herguido, Sandra Amuedo, Gema López-Gallardo, Carmen Amelia Ruiz-Trillo, Fernando López Herrero, María Loreto Saez Ortega, Ana Muñoz Morales, Virginia Bellido, Alfonso Soto-Moreno

10.1177/15209156261481005
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A covering letter is required when writing or editing assistance from a third party is disclosed, when a submission is made on behalf of the authors by a non-author, and a confirmatory letter may be uploaded for consent to publish information.

Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

What are the publication costs?

Mandatory page charges are $90/page upon acceptance. Optional open access publishing is available for a fee via Sage Choice.

Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Research Topics

Diabetes Management and Research Pancreatic function and diabetes Diabetes and associated disorders Diabetes Treatment and Management Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Management and Education Metabolism, Diabetes, and Cancer Mobile Health and mHealth Applications Diabetes, Cardiovascular Risks, and Lipoproteins Diet and metabolism studies Gestational Diabetes Research and Management Spectroscopy Techniques in Biomedical and Chemical Research Electrochemical sensors and biosensors Heart Rate Variability and Autonomic Control Inhalation and Respiratory Drug Delivery Diabetic Foot Ulcer Assessment and Management Cardiovascular Function and Risk Factors Pharmacology and Obesity Treatment Pharmaceutical studies and practices Botulinum Toxin and Related Neurological Disorders Chronic Disease Management Strategies Natural Antidiabetic Agents Studies Advanced Glycation End Products research Adipose Tissue and Metabolism Medication Adherence and Compliance

Related Journals

CM
Cell Metabolism CELL PRESS
TA
Therapeutic Advances in Endocrinology and Metabolism SAGE Publishing
Me
Metabolism Elsevier BV
NM
Nature Metabolism NATURE PORTFOLIO
MA
Molecular and Cellular Endocrinology Elsevier BV
EJ
European Journal of Endocrinology Oxford University Press